Click here to read the articles and download the PDF

Pharmaceutical Commerce - October 2024

Alongside the proper temperature-monitoring technology, optimal production control is necessary for success in cold chain drug delivery.

Keeping Do-Not-Freeze Injectable Drugs Safe Through the Last Mile

Why this trend is occurring and ways that drugmakers are pivoting in order to remedy the situation.

Who Moved My Prescription? Part VI: Abandonment of Branded Prescriptions

When it comes to navigating the complex clinical and commercial landscape for specialty drugs—including hurdles in access to these critical but costly therapies—today’s specialty pharmacies are bringing more skills and services to the table.

Specialty Pharmacy: The Trends Shaping Best Practices

Articles

Cost Plus Drug Co. adds J&J's Janssen medications to its offerings, increasing affordability for diabetes patients.

Mark Cuban's Cost Plus Drug Co. Expands to Offer J&J Brand-Name Medications

The platform agnostic CGT hub hopes to streamline the path-to-care process, by providing physicians and patient services teams with visibility across the therapy development and delivery process. 

AmerisourceBergen Launches Cell and Gene Therapy Integration Hub

CDMO’s fill-finish line offers batch capacity of over 200,000 syringes.

Ajinomoto HPAPI Line Receives FDA Approval 

Michael Wong is an Emeritus Board Member of the Harvard Business School Healthcare Alumni Association.

In this latest Harvard Business School Healthcare Alumni Association Q&A, Dr. Peter Cappelli, Professor of Management at The Wharton School and Director of Wharton’s Center for Human Resources, explains how biopharma C-suites can lead their teams through 2023’s turbulent times. 

Traversing the Biopharma Career Landscape 

Podcasts

Non-profit executive details ways to ensure supply chain resilience during emergencies. 

Protecting Patient Access to Medication in the Midst of Crisis

Purchase solidifies group’s goal of expanding patient access to rare disease treatments. 



Chiesi Farmaceutici S.p.A. Officially Acquires Amryt Pharma Plc

Company will also financially commit $15 million for those pursuing pharma manufacturing careers.

Lilly Invests Total of $3.7 Billion toward Indiana Location, a Company Record

Joint initiative integrates submitted claims with parties’ platforms in effort to avoid duplicate data.

IntegriChain, Second Sight Solutions Form 340B Issue Prevention Collaboration

Company acquires Makara Health, who will work alongside Precision’s branded medical and scientific agency.

Precision Value & Health Grows Communications Services in Europe

Merger with pharmacovigilance service provider helps company expands its end-to-end solutions in the region.

Featured Content

Pharmaceutical Commerce - October 2024

Keeping Do-Not-Freeze Injectable Drugs Safe Through the Last Mile

Who Moved My Prescription? Part VI: Abandonment of Branded Prescriptions

Specialty Pharmacy: The Trends Shaping Best Practices